Current through 2023-2024 Legislative Session Chapter 709
Section 16-13-71 - Dangerous drug(a) A "dangerous drug" means any drug other than a drug contained in any schedule of Article 2 of this chapter, which, under the federal Food, Drug, and Cosmetic Act (52 Stat. 1040 (1938)), 21 U.S.C. Section 301, et seq., as amended, may be dispensed only upon prescription. In any civil or criminal action or other proceedings, a certification from the Food and Drug Administration of the United States Department of Health and Human Services attesting to the fact that a drug other than a drug contained in any schedule of Article 2 of this chapter involved in the action or proceeding is a dangerous drug that federal law prohibits dispensing of without a prescription pursuant to the federal Food, Drug, and Cosmetic Act shall be admissible as prima-facie proof that such drug is a "dangerous drug."(b) In addition to subsection (a) of this Code section, a "dangerous drug" means any other drug or substance declared by the General Assembly to be a dangerous drug; to include any of the following drugs, chemicals, or substances; salts, isomers, esters, ethers, or derivatives of such drugs, chemicals, or substances which have essentially the same pharmacological action; all other salts, isomers, esters, ethers, and compounds of such drugs, chemicals, or substances unless specifically exempted and the following devices, identified as "dangerous drugs": (.043) AbobotulinumtoxinA;(4.1) Aceto-hydroxamic acid;(7) Acetyl sulfamethoxypyridazine;(8) Acetyl sulfisoxazole;(12.5) Aclidinium bromide;(13.531) Adalimumab-atto;(13.54) Adamts13, recombinant-krhn;(13.55) Adapalene - See exceptions;(14) Adenosine 5-monophosphate;(16) Adiphenine hydrochloride;(17) Adrenal cortex extracts;(17.4) Air polymer-type A;(18) Albumin, normal human serum;(19.3) Alcaftadine - See exceptions;(19.5) Alclometasone dipropionate;(19.75) Alglucosidase alfa;(21.3) Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat;(21.5) Allogeneic processed thymus tissue-agdc;(25) Aluminum nicotinate;(28) Ambenonium chloride;(29) Ambrosiacae follens;(33) 4-amino-N-methyl-pteroylglutamic acid;(34) Amino acid preparations for injection or vaginal use;(36.5) Aminolevulinic acid;(38) Aminosalicylate - See exceptions;(39) Aminosalicylate calcium - See exceptions;(40) Aminosalicylate potassium - See exceptions;(41) Aminosalicylate sodium - See exceptions;(42) Aminosalicylic acid - See exceptions;(50.1) Anabolic steroids, if listed in Code Section 16-13-27.1 as being exempt as Schedule III controlled substances;(51) Androgens, except those androgens listed in paragraph (6) of Code Section 16-13-27;(56) Anterior pituitary hormones;(57.5) Anthrax Vaccine Adsorbed, Adjuvanted;(58) Anti-coagulant acid:(58.5) Anticoagulant sodium citrate 4 percent solution;(59) Antigens:(D) Aspergillus fumigatus;(E) Bacterial, Staphylococcus aureus, Type 1;(F) Bacterial, Staphylococcus aureus, Type 3;(G) Bacterial, Undenatured;(Q) Coccidioides immitis;(W) Gram negative bacterial;(X) Helminthosporium sativum;(BB.5) House Dust Mite Allergen Extract;(EE) Intradermal or scratching test;(GG) Kentucky blue grass;(MM) Mixed grass, ragweeds (spring-fall);(NN) Mixed grasses (spring);(RR) Mixed ragweed - mixed weeds (fall);(BBB) Penicillium notatum;(DDD) Poison oak and poison ivy;(JJJ) Respiratory bacterial;(PPP) Simplified allergy screening set;(TTT) Stinging insect mix;(AAAA) Trees (early spring);(60) Antihemophilic factor, Human;(60.3) Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl;(60.5) Anti-human globulin;(62.75) Arformoterol tartrate;(64) Arsenic - Preparation for human use;(66) Ascorbate sodium - Injection;(67.3) Asparaginase erwinia chrysanthemi (recombinant)-rywn;(68.4) Atracurium besylate;(68.5) Atropine - See exceptions;(69.02) Avacincaptad pegol;(69.05) Avalglucosidase alfa-ngpt;(69.25) Axicabtagene ciloleucel;(72.4) Azelastine - See exceptions;(75) Bacitracin - See exceptions;(76.3) Baloxavir marboxil;(77) Barium - See exceptions;(78.2) Belantamab mafodotin-blmf;(80) Belladonna alkaloids;(81) Belladonna extracts;(83) Bendroflumethiazide;(83.5) Bentoquatam - See exceptions;(90) Benzylpenicilloyl - polylysine;(91) Bephenium hydroxynaphthoate;(91.73) Beremagene geperpavec-svdt;(92) Beta-carotene - See exceptions;(93) Betadine vaginal gel;(94.5) Betaine, anhydrous;(97.1) Bethanidine sulfate;(97.105) Betibeglogene autotemcel;(97.7) Bictegravir sodium;(99.5) Birch triterpenes;(101) Bishydroxycoumarin;(102) Bismuth sodium tartrate - See exceptions;(102.1) Bitolterol mesylate;(105) Boroglycerin glycerite;(105.7) Botulinum toxin (B);(106) Botulism antitoxin;(106.5) Brentuxima vedotin;(107.45) Brilliant blue G ophthalmic solution;(107.7) Brolucizumab-dbll;(108) Bromelains - See exceptions;(111) Bromodiphenhydramine;(112) Brompheniramine - See exceptions;(114) Brucella protein nucleate;(115.3) Budesonide - See exceptions;(119.05) Butenafine - See exceptions;(119.1) Butoconazole - See exceptions;(123) Cadmium sulfide - See exceptions;(124) Caffeine sodium benzoate;(124.1) Calaspargase pegol-mknl;(125) Calcitonin, Salmon;(127) Calcium disodium edetate - See exceptions;(128) Calcium gluconogalactogluconate;(129) Calcium levulinate;(132.7) Caplacizumab-yhdp;(133.05) Capsaicin - See exceptions;(146) Casein hydrolysate;(147) Catarrhalis combined vaccine;(148) Catarrhalis vaccine mixed;(154) Cellulose, Oxadized, Regenerated - See exceptions;(154.5) Centruroides [Scorpion] Immune;(159.9) Cerliponase alfa;(160.15) Cetirizine - See exceptions;(160.5) Chikungunya Vaccine, Live;(164) Chloranil - See exceptions;(166) Chlordiazepoxide in combination with clidinium bromide or water soluble esterified estrogens;(166.5) Chlorhexidine - See exceptions;(170) Chloroacetic acid - See exceptions;(171) Chlorobutanol - See exceptions;(172) Chloroform - See exceptions;(180) Chlorpheniramine - See exceptions;(190) Cholestyramine resin;(192.8) Ciltacabtagene autoleucel;(193) Cimetidine - See exceptions;(194.2) Cipaglucosidase alfa-atga;(196) Clemastine - See exceptions;(198.1) Clobetasol propionate;(199) Clocortolone pivalate;(204) Clostridiopeptidase;(205) Clotrimazole - See exceptions;(206.7) Coagulation Factor X, (human);(207) Coal tar solution topical;(208.5) Coccidioides immitis;(209) Colchicine - See exceptions;(213.1) Collagenase clostridium histolyticum;(213.45) Copper dotatate Cu-64;(215) Corticotropin, Respository;(217.2) COVID-19 Vaccine, mRNA;(217.7) Crizanlizumab-tmca;(218) Cromolyn - See exceptions;(219) Crotaline antivenin, Polyvalent;(221.5) Cupric chloride - injectable;(240) Dapsone - See exceptions;(240.5) Darbepoetin alfa;(241.5) DaxibotulinumtoxinA-lanm;(244.45) Delandistrogene moxeparvovec-rokl;(247) Demethylchlortetracycline;(247.4) Dengue Tetravalent Vaccine, Live;(247.8) Deoxycholic Acid;(248) Deoxyribonuclease, Pancreatic;(255) Desoxycorticosterone;(256) Desoxyribonuclease;(256.55) Deucravacitinib;(256.6) Deutetrabenazine;(258) Dexbrompheniramine - See exceptions;(259) Dexchlorpheniramine;(264) Dextroisoephedrine;(269) Dichloralphenazone;(270.5) Diclofenac - See exceptions;(274) Diethylcarbamazine;(275) Diethylstilbestrol;(277) Diflorasone diacetate;(281) Dihydroergocornine;(282) Dihydroergocristine;(283) Dihydroergocryptine;(285) Dihydrostreptomycin;(286) Dihydrotachysterol;(288) Dimenhydrinate - Injection or suppositories;(291.5) Dimethyl fumarate;(292) Dimethyl sulfoxide - See exceptions;(293) Dimethyl tubocurarine;(299) Diphenhydramine - See exceptions;(303) Diphtheria antitoxin;(304) Diphtheria and tetanus toxoids;(305) Diphtheria and tetanus toxoids and pertussis vaccine;(306) Diphtheria and tetanus toxoids, Absorbed;(307) Diphtheria and tetanus toxoids, Pertussis;(312) Disodium edetate - See exceptions;(315.7) Docosanol - See exceptions;(317.45) Dostarlimab-gxly;(318.5) Doxazosin mesylate;(325.4) Drotrecogin alfa;(328.3) Ebola Zaire Vaccine, Live;(330.5) Edetate - See exceptions;(331.033) Efbemalenograstim alfa-vuxw;(331.035) Efgartigimod alfa-fcab;(331.051) Elagolix sodium;(331.052) Elapegademase-lvlr;(331.0535) Elecsys HIV Duo;(331.0536) Elecsys HTLV-I/II;(331.056) Elivaldogene autotemcel;(331.0595) Elranatamab-bcmm;(331.068) Emapalumab-lzsg;(332.1) Enfortumab vedotin-ejfv;(332.875) Epcoritamab-bysp;(332.88) Epidiolex: A drug product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the United States Food and Drug Administration (FDA) that contains cannabidiol (CBD) derived from cannabis and contains no more than 0.1 percent (w/w) residual tetrahydrocannabinols;(333) Epinephrine - See exceptions;(334.85) Eptinezumab-jjmr;(335) Ergocalciferol - See exceptions;(335.5) Ergoloid mesylates;(347) Erythrityl tetranitrate;(349.7) Esomeprazole - See exceptions;(350) Esterified estrogens;(354) Estrogenic substances;(359.5) Ethanolamine oleate;(361) Ether - See exceptions;(370) Ethoxazene - See exceptions;(372) Ethyl biscoumacetate;(373) Ethyl chloride - See exceptions;(374) Ethyl nitrite spirit;(376) Ethylnorepinephrine;(377) Ethynodiol diacetate;(380.35) Evinacumab-dgnb;(381) Factor IX complex, Human;(381.2) Famotidine - See exceptions;(381.24) Fecal microbiota spores, live-brpk;(381.75) Fenofibric acid;(383.15) Ferric Hexacyanoferrate;(383.5) Fexofenadine - See exceptions;(385) Fibrinogen/antihemophilic factor, Human;(386) Fibrinolysin, Human;(386.9) Fish oil triglycerides;(387.1) Flecainide acetate;(388.3) Florbetapir F 18;(388.4) Flortaucipir F 18;(388.7) Flotufolastat F 18;(396) Fluoride - See exceptions;(396.4) Fluoroestradiol F 18;(402.6) Flutemetamol F18;(402.7) Fluticasone - See exceptions;(404) Folic acid - See exceptions;(406) Formaldehyde - See exceptions;(406.94) Fremanezumab-vfrm;(408.4) Gadopentetate dimeglumine;(408.5) Gadoterate meglumine;(408.95) Galcanezumab-gnlm;(409) Gallamine triethiodide;(409.1) Gallium 68 PSMA-11;(410) Gamma benzene hexachloride;(412) Gas gangrene polyvalent antitoxin;(412.3) Gemtuzumab ozogamicin;(414) Gentian violet vaginal suppositories;(418) Gluconate magnesium;(419) Gluconate potassium - See exceptions;(420) Glutamate arginine;(420.2) Glycerol phenylbutyrate;(420.5) Glycine - See exceptions;(423) Gold sodium thiomalate;(424) Gold thiosulfate - See exceptions;(425.5) Gonadorelin acetate;(426) Gonadotropin, Chorionic;(427) Gonadotropin, Chorionic, Anti-human serum;(428) Gonadotropin, Serum;(433.5) Halobetasol Propionate;(437) Hartman's solution;(438.3) Hepatitis C virus (E. coli, recombinant) NS3 helicase antigens and synthetic core peptide;(438.5) Hepatitis vaccine;(440) Hexachlorophene - See exceptions;(445.5) Histrelin acetate;(446.2) Human Papillomavirus 9-valent Vaccine, Recombinant;(450) Hydrochlorothiazide;(452) Hydrocortisone - See exceptions;(453) Hydroflumethiazide;(455) Hydroxocobalamin - See exceptions;(456) Hydroxyamphetamine;(457) Hydroxychloroquine;(458) Hydroxyprogesterone;(462) Hyoscyamus alkaloids;(462.5) Hyperpolarized Xe-129;(463.01) Ibalizumab-uiyk;(464) Ibuprofen - See exceptions;(464.17) Idecabtagene vicleucel;(465.1) Imipenem/cilastatin;(467) Immune hepatitis B globulin, Human;(468) Immune poliomyelitis globulin, Human;(469) Immune serum globulin, Human;(469.05) IncobotulinumtoxinA;(470) Indigotindisulfonate;(470.1) Indium IN-III oxyquinolone;(470.3) Indium IN-III pentetreotide;(472.3) Inebilizumab-cdon;(472.51) Infliximab-dyyb;(473) Influenza virus vaccines;(473.5) Ingenol mebutate;(474) Injections, All substances for human use - See exceptions;(474.1) Inotuzumab ozogamicin;(474.3) Insulin degludec;(474.4) Insulin glargine;(474.45) Insulin glulisine;(475) Intrinsic factor concentrate manufactured for human use;(478) Iodinated I-125 serum albumin;(479) Iodinated I-131 serum albumin;(480) Iodinated glycerol-theophylline;(481) Iodine solution, Strong oral;(484) Iodobenzoic acid - See exceptions;(485.1) Iodohippurate sodium;(488) Iopanoic acid - See exceptions;(493) Iron dextran injection;(504) Isosorbide dinitrate;(504.05) Isosorbide mononitrate;(506.8) Ivermectin - See exceptions;(509) Ketocholanic acids;(509.1) Ketoconazole - See exceptions;(509.15) Ketoprofen - See exceptions;(509.17) Ketorolac tromethamine;(509.18) Ketotifen - See exceptions;(510) Lactated ringers solution;(512.5) Lansoprazole - See exceptions;(512.8) Latanoprostene bunod;(513) Latrodectus mactans;(516.75) Levocetirizine dihydrochloride - See exceptions;(517.35) Levomilnacipran;(520) Lidocaine - See exceptions;(522) Lindane - See exceptions;(525.7) Lisocabtagene maraleucel;(526) Lithium carbonate - See exceptions;(528.4) Lofexidine hydrochloride;(529.07) Lonapegsomatropin-tcgd;(529.08) Loncastuximab tesirine-lpyl;(529.1) Loperamide - See exceptions;(529.9) Loratadine - See exceptions;(531.45) Lumateperone tosylate;(531.75) Luspatercept-aamt;(531.9) Lutetium Lu 177 dotatate;(531.95) Lutetium (177Lu) vipivotide tetraxetan;(533) Lymphogranuloma venereum antigen;(534) Lypressin synthetic;(536) Magnesium gluconate - See exceptions;(537) Magnesium salicylate;(538) Mandelic acid - See exceptions;(539) Mannitol - See exceptions;(540) Mannitol hexanitrate;(540.4) Margetuximab - anti HER2 mAb;(541) Measles immune globulin, Human;(542) Measles virus vaccines;(543) Mebendazole for human use;(546) Meclizine - See exceptions;(548) Medroxyprogesterone;(556) Meningococcal vaccine;(567) Mercury bichloride - See exceptions;(581) Methenamine hippurate;(582) Methenamine mandelate;(583) Methenamine sulfosalicylate;(595.5) Methoxy polyethylene glycol-epoetin beta;(599) Methylandrostenediol;(603) Methylene blue, Oral;(604.5) Methylnaltrexone;(605) Methylprednisolone;(609) Metocurine iodide injection;(616) Miconazole - See exceptions;(617) Microfibrillar collagen hemostat;(619) Minoxidil - See exceptions;(619.2) Mirikizumab-mrkz;(619.4) Mirvetuximab soravtansine-gynx;(623.5) Mometasone - See exceptions;(625.05) Mosunetuzumab-axgb;(625.2) Moxetumomab pasudotox-tdfk;(626) Mumps virus vaccines;(627) Mushroom spores which, when mature, contain either psilocybin or psilocin;(628) N-acetyl-1-cysteine;(629) N. cattarhalis antigen;(635) Naloxone - See exceptions;(637) Naphazoline - See exceptions;(638) Naproxen - See exceptions;(639) Neomycin - See exceptions;(640.11) Neratinib maleate;(640.5) Niacinamide - See exceptions;(641.1) Nicotine resin complex (polacrilex) - See exceptions;(641.15) Nicotine transdermal system - See exceptions;(644.65) Nirsevimab-alip;(644.9) Nitric oxide - for use in humans;(648) Nitroprusside - See exceptions;(648.3) Nitrous oxide - See exceptions;(648.6) Nizatidine - See exceptions;(649.1) Nomifensine maleate;(650) Nonoxynol - See exceptions;(654) Norgestrel - See exceptions;(655) Normal serum albumin, Human;(661.03) Obeticholic acid;(661.5) Octreotide acetate;(661.55) Odesivimab-ebgn;(663.2) Olopatadine - See exceptions;(663.3) Olsalazine Sodium;(663.35) Omacetaxine mepesuccinate;(663.5) Omeprazole - See exceptions;(663.55) Omidenepag isopropyl;(663.57) Omidubicel-onlv;(663.6) OnabotulinumtoxinA;(663.75) Orlistat - See exceptions;(665) Orthoiodobenzoic acid;(665.7) Ovine hyaluronidase;(671) Oxybutynin - See exceptions;(672) Oxygen for human use - See exceptions;(681) P-nitrosulfathiazole;(682) Pancreatin dornase;(689) Paranitrosulfathiazole;(690) Parathyroid injection;(692.4) Pegademase bovine;(692.518) Pegunigalsidase alfa-iwxj;(692.519) Pegvaliase-pqpz;(699) Pentaerythritol tetranitrate;(700.1) Pentamidine isethionate;(701.5) Pentetate calcium trisodium;(701.7) Pentetate zinc trisodium;(703.4) Pentylenetetrazol;(703.6) Perfluoroalkylpolyether;(703.63) Perfluorohexyloctane;(704.1) Permethrin - See exceptions;(706) Pertussis immune globulin, Human;(710) Phenazopyridine - See exceptions;(716) Pheniramine - See exceptions;(718) Phenothiazine derivatives;(720) Phenoxymethyl penicillin;(725) Phenylmercuric acetate;(726) Phenylmercuric nitrate;(726.5) Phenylpropanolamine;(727) Phenyltoloxamine dihydrogen citrate;(728) Phthalylsulfacetamide;(729) Phthalylsulfathiazole;(731.05) Piflufolastat F 18;(742) Plasma protein fraction;(742.03) Plasminogen, human-tvmh;(743) Pneumococcal vaccine;(744) Poison ivy extract;(745) Poison ivy oak extract;(746) Poison ivy oak, sumac extract;(746.5) Polatuzumab vedotin-piiq;(747) Poldine methylsulfate;(748) Poliomyelitis vaccine;(749) Poliovirus vaccine, Live, Oral, All;(751) Polymyxin B - See exceptions;(751.5) Polytetrafluoroethylene;(753) Posterior pituitary;(754) Potassium acetate injection;(755) Potassium acid phosphate - See exceptions;(756) Potassium p-aminobenzoate - See exceptions;(757) Potassium aminosalicylate - See exceptions;(758) Potassium arsenite - See exceptions;(759) Potassium bicarbonate - See exceptions;(760) Potassium carbonate - See exceptions;(761) Potassium chloride - See exceptions;(762) Potassium citrate - See exceptions;(763) Potassium gluconate - See exceptions;(764) Potassium hetacillin;(765) Potassium iodide - See exceptions;(767) Potassium permanganate - See exceptions;(768) Povidone - Iodine - See exceptions;(768.5) PrabotulinumtoxinA-xvfs;(780) Procaine penicillin;(781) Procaine penicillin G;(791) Prophenpyridamine - See exceptions;(798) Protamine sulfate injection;(799) Protein hydrolysate injection;(800) Protein, Foreign injection;(801) Proteolytic enzyme;(801.5) Prothrombin complex concentrate, human-lans;(804) Protoveratrine A and B;(807) Pseudomonas polysaccharide complex;(808) P-ureidobenzenearsonic acid;(809) Purified protein derivatives of tuberculin;(821) Quinine hydrochloride;(822) Quinine and urea hydrochloride;(824) Rabies immune globulin, Human;(826) Radio-iodinated compounds;(831) Ragweed pollen extract;(831.1) Ranitidine - See exceptions;(832) Rauwolfia serpentina;(835) Reserpine alkaloids;(836) Resorcinol monoacetate - See exceptions;(836.1) Respiratory Syncytial Virus Vaccine;(836.4) Retifanlimab-dlwr;(836.5) Retinoic acid, all-trans;(837) Rhus toxicodendron antigen;(838) Rh D immune globulin, Human;(839) Riboflavin - See exceptions;(843) Ringer's injection;(843.15) Risankizumab-rzaa;(844) Rocky mountain spotted fever vaccine;(845.2) Romosozumab-aqqg;(845.25) Ropeginterferon alfa-2b-njft;(845.9) Rotavirus vaccine;(846.3) Rozanolixizumab-noli;(847) Rubella and mumps virus vaccine;(848) Rubella virus vaccine;(849) Rutin - See exceptions;(849.3) Sacituzumab govitecan-hziy;(850) Salicylazosulfapyridine;(851) Salmonella typhosa, Killed;(851.03) Samarium SM 153 lexidronam;(851.1) Saralasin acetate;(851.5) Satralizumab-mwge;(852.5) Segesterone acetate;(853) Selenium sulfide - See exceptions;(853.5) Selenomethionine;(854) Senecio cineraria extract ophthalmic solution;(855) Senega fluid extract;(855.3) Seractide acetate;(855.5) Sermorelin Acetate;(856) Silver nitrate ophthalmic solutions or suspensions;(857) Silver sulfadiazine cream;(857.3) Simethicone coated cellulose suspension;(860) Solutions for injections, All;(862) Sodium acetate injection;(863) Sodium acetrizoate;(864) Sodium ascorbate injection;(865) Sodium biphosphate - See exceptions;(867) Sodium chloride injection - See exceptions;(868) Sodium dehydrocholate;(869) Sodium dextrothyroxine;(871) Sodium fluorescein - See exceptions;(872) Sodium fluoride - See exceptions;(873) Sodium iothalamate;(873.5) Sodium nitroprusside;(873.7) Sodium phenylbutyrate;(873.8) Sodium picosulfate;(874) Sodium polystyrene sulfonate;(875) Sodium propionated vaginal cream;(876) Sodium sulfacetamide;(877) Sodium sulfadiazine;(878) Sodium sulfobromophthalein;(880.5) Sodium thiosulfate;(881) Sodium tyropanoate;(881.01) Sodium zirconium cyclosilicate;(881.07) Somapacitan-beco;(888) Staphage lysate bacterial antigen;(889) Staphylococcus and streptococcus vaccine;(890) Staphylococcus toxoid;(892) Stinging insect antigens - Combined;(893) Stockes expectorant;(895) Streptococcus antigen;(896) Streptokinase-streptodornase;(898) Strontium - See exceptions;(900) Strychnine - See exceptions;(903) Succinylsulfathiazole;(903.15) Sucroferric oxyhydroxide;(904) Sulfabenzamide vaginal preparations;(906) Sulfachlorpyridazine;(917) Sulfamethoxypyridazine;(926) Sulfur thioglycerol;(930.901) Tafamidis meglumine;(930.905) Tafasitamab-cxix;(930.97) Tagliglucerase alfa;(930.975) Tagraxofusp-erzs;(930.99) Talquetamab-tgvs;(931.4) Tebentafusp-tebn;(931.505) Teclistamab-cqyv;(931.61) Telotristat ethyl;(931.81) Teplizumab-mzwv;(931.83) Teprotumumab-trbw;(931.95) Terbinafine - See exceptions;(933) Terpin hydrate with codeine;(936) Tetanus and diphtheria toxoids;(938) Tetanus immune globulin;(942) Tetraethylammonium chloride;(943) Tetrahydrozoline - See exceptions;(943.4) Tezepelumab-ekko;(946) Theobromine magnesium oleate;(947) Theophylline - See exceptions;(948) Theophylline sodium glycinate;(964) Thyroxine fraction;(965.3) Tick-borne encephalitis vaccine;(967.3) Tioconazole - See exceptions;(967.62) Tisagenlecleucel;(967.63) Tisotumab vedotin-tftv;(973.45) Toripalimab-tpzi;(973.65) Tralokinumab-ldrm;(974.6) Tremelimumab-actl;(976) Triamcinolone - See exceptions;(978) Trichlormethiazide;(979) Trichloroacetic acid - See exceptions;(980) Trichloroethylene - See exceptions;(983) Tridihexethyl chloride;(984) Triethanolamine polypeptides;(985) Triethylenethiophosphoramide;(993) Trimethaphan cansylate;(999) Tripelennamine - See exceptions;(1000) Triphenyltetrazolium;(1002) Triprolidine - See exceptions;(1003) Trisulfapyrimidines;(1009) Trypsin-chymotrypsin;(1011) Tuberculin, Purified protein derivatives;(1012) Tuberculin tine test;(1016) Typhoid and paratyphoid vaccine;(1018.2) Ublituximab-xiiy;(1021) Urea - See exceptions;(1022.5) Valoctocogene roxaparvovec-rvox;(1024) Valproic acid - See exceptions;(1025.8) Varicella Virus Vaccine Live;(1027.1) Vecuronium bromide;(1027.4) Velmanase alfa-tycv;(1029.6) Vestronidase alfa-vjbk;(1033) Vinyl ethyl - See exceptions;(1036) Vitamin B12 injection;(1037) Vitamine with fluoride;(1037.23) von Willebrand factor;(1040) Yellow fever vaccine;(1042) 4-chloro-3, 5-xylenol - See exceptions;(1042.7) Zinc acetate - See exceptions;(1042.78) Ziv-aflibercept;(1042.8) Zoledronic Acid;(1042.95) Zoster Vaccine Recombinant, Adjuvanted;(1043) Devices that require a prescription: (A) Cellulose, Oxadized, Regenerated (surgical absorbable hemostat) - See exceptions;(B) Diaphragms for vaginal use;(C) Hemodialysis solutions;(E) Lippes loop intrauterine;(F) Saf-T-Coil intrauterine device;(G) Intrauterine devices, All;(b.1) A "restricted dangerous drug" means any other drug or substance declared by the General Assembly to have no medical use, which cannot be legally prescribed by a practitioner, and which cannot be manufactured, grown, produced, distributed, used, or otherwise possessed in this state; to include any of the following drugs, chemicals, or substances; salts, isomers, esters, ethers, or derivatives of such drugs, chemicals, or substances which have essentially the same pharmacological action; and all other salts, isomers, esters, ethers, and compounds of such drugs, chemicals, or substances unless specifically exempted, identified as "restricted dangerous drugs": (2) Salvia divinorum - except as otherwise provided for in paragraph (4.3) of Code Section 16-13-72. This subsection shall not prohibit a person from possessing a restricted dangerous drug for the purpose of conducting research approved by the federal Food and Drug Administration.
(c) The following are exceptions to and exemptions from subsection (b) of this Code section: (0.5) Adapalene - when used with a strength up to 0.1 percent in a topical skin product;(0.7) Alcaftadine - when used in a concentration of 0.25 percent or less in an ophthalmic solution;(1) Atropine sulfate - where the oral dose is less than 1/200 gr. per unit;(1.5) Azelastine hydrochloride - when used in a concentration of 0.15 percent or less in a nasal spray or nasal solution;(2) Bacitracin cream or ointment for topical use;(3) Belladonna or belladonna alkaloids when in combination with other drugs and the dosage unit is less than 0.1 mg. of the alkaloids or its equivalent;(3.5) Bentoquatam - when used with a strength of 5 percent or less in topical preparations;(4) Beta carotene - all forms occurring in food products or lotions;(5) Bromelain, pancreatic enzymes, trypsin and bile extract - when labeled properly as digestive aids with appropriate dosage and in compliance with FDA labeling and restrictions;(6) Brompheniramine - where a single dosage unit is 4 mg. or less but with no more than 3 mg. of the dextrorotary optical isomer of racemic brompheniramine per released dose;(6.1) Budesonide - when used as a nasal spray in doses up to 32 mcg. per spray;(6.2) Butenafine - when used with a strength of 1 percent or less as a topical preparation;(6.4) Butoconazole - when used with a strength up to 2 percent in a vaginal preparation;(6.45) Capsaicin - when in an external analgesic with concentration of 0.25 percent or less;(6.5) Cetirizine - when a single dosage unit is either 1 mg. per 1 ml. or less or 10 mg. or less;(6.7) Chlorhexadine - when used with a strength up to 4 percent in a topical skin product;(7) Chlorpheniramine - where a single dosage unit is 12 mg. or less;(7.1) Cimetidine - when a single dosage unit is 200 mg. or less;(7.3) Clemastine - where a single dose is 1.34 mg. or less;(7.5) Clotrimazole - when a single vaginal insert is 200 mg. or less or with a strength up to 2 percent in a topical skin, topical vaginal, or vaginal product;(7.8) Cromolyn - when used as cromolyn sodium in a nasal solution of 4 percent or less in strength;(7.9) Dexbrompheniramine - when a single dosage unit is 6 mg. or less;(7.95) Diclofenac Sodium - When used with a strength of 1 percent or less in a topical gel;(8) Diphenhydramine - up to 12.5 mg. in each 5 cc's when used in cough preparations and up to 50 mg. per single dose when used as a nighttime sleep aid or used as an antihistamine and labeled in compliance with FDA requirements;(8.5) Docosanol - when used in 10 percent topical preparation to treat fever blisters, cold sores, or fever blisters and cold sores.(9) Doxylamine succinate - where a single dosage form is 25 mg. or less and when labeled to be used as a nighttime sedative;(9.3) Edetate - when used in any form other than an oral or parenteral;(9.33) Epinephrine - when used in a device that delivers a metered spray of 0.125 mg. of epinephrine or less to provide temporary relief for symptoms of mild, intermittent asthma and is a product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA);(9.4) Esomeprazole - when a single dosage unit is 20 mg. or less;(9.5) Famotidine - when a single dosage unit is 20 mg. or less;(9.6) Fexofenadine - when packaged for distribution as an over-the-counter (OTC) drug product;(9.7) Fluoride - when used with a strength up to 1,500 parts per million in an oral care or dentifrice product;(9.75) Fluticasone - when available in a device that delivers a metered spray of 0.05 mg. and to be used for the temporary relief of symptoms due to hay fever or other upper respiratory allergies;(9.8) Glycine - when used with a strength up to 1.5 percent in an irrigation solution, when used in a topical skin product;(10) Hydrocortisone topical skin preparations up to 1 percent in strength;(11) Hydroxocobalamin, riboflavin, niacinamide, ergocalciferol (maximum of 400 I.U. per day), Folic acid (maximum of 0.4 mg. per day), and magnesium gluconate - when as a source of vitamins and dietary supplement but must bear such labels and adhere to such restrictions of FDA regulations;(11.1) Ibuprofen - where a single dose is 200 mg. or less;(12) Insulin - all injectable products which do not require a prescription drug order and bear a label which indicates "Rx Use Only" or are otherwise listed under subsection (b) of this Code section; and no injectable insulin product may be sold except by a pharmacy issued a permit by the State Board of Pharmacy or by a medical practitioner authorized to dispense medications;(12.1) Ivermectin - When used with a strength of 0.5 percent or less in a topical lotion;(12.3) Ketoconazole - when used with a strength of 1 percent or less in topical preparations;(12.5) Ketoprofen - when a single dosage unit is 12.5 mg. or less;(12.7) Ketotifen - when used with a strength of 0.025 percent or less in an ophthalmic solution;(12.9) Lansoprazole - when a single dosage unit is 15 mg. or less;(12.91) Levocetirizine - when a single dose unit is either 2.5 mg. per 5 ml. or less or 5 mg. or less;(12.95) Levocetirizine dihydrochloride - when used in a single dose of 5 mg. or less;(13) Lidocaine topical, 40 mg./gm. (4 percent) or less;(13.5) Loperamide - where a single dose is either 1 mg. per 5 ml. or 2 mg. per dosage unit;(13.7) Loratadine - when used in a single dose of 10 mg. or less, including doses used in combination with other drugs provided for under this subsection;(14) Meclizine - 25 mg. or less;(14.1) Miconazole - when used as antifungal powder or cream, or both, and containing not more than 4 percent of miconazole, or when used as a vaginal insert and containing not more than 1,200 mg. of miconazole;(14.2) Minoxidil - when used with a strength of 5 percent or less in topical preparations;(14.23) Mometasone - when used as mometasone furoate in a nasal spray in doses up to 50 mcg per spray;(14.25) Naloxone - shall also be exempt from subsections (a) and (b) of this Code section when used for drug overdose prevention as follows:(A) Nasal adaptor rescue kits containing a minimum of two prefilled 2 ml. luer-lock syringes with each containing 1 mg./ml. of naloxone;(B) Prepackaged nasal spray rescue kits containing single-use spray devices with each containing a minimum of 4 mg./0.1 ml. of naloxone;(C) Muscle rescue kits containing a 10 ml. multidose fliptop vial or two 1 ml. vials with a strength of 0.4 mg./ml. of naloxone when supplied by a dispenser or licensed distributor or wholesaler; or(D) Prepackaged kits of two muscle autoinjectors with each containing a minimum of 0.4 mg./ml. of naloxone when supplied by a dispenser or licensed distributor or wholesaler;(14.3) Naphazoline - when used in an ophthalmic solution in a concentration of 0.027 percent or less in combination with a pheniramine concentration of 0.315 percent or less;(14.5) Naproxen - where a single dosage unit is 220 mg. or less;(15) Neomycin sulfate ointment or cream for topical use;(15.5) Nicotine resin complex (polacrilex) - when used as oral chewing gum where a single dose (piece of gum) is 4 mg. or less;(15.55) Nicotine transdermal system - when used in a strength of 21 mg. or less per transdermal patch (transdermal delivery system);(16) Nitrous oxide - air products suppliers shall not sell medical grade nitrous oxide to other than licensed practitioners or medical suppliers; industrial grade nitrous oxide shall only be sold when mixed with not less than 100 parts per million of sulfur dioxide and used as a fuel additive for combustion engines or when used in industrial laboratory equipment;(16.3) Nizatidine - when a single dosage unit is 75 mg. or less;(16.8) Nonoxynol - when used with a strength up to 12.5 percent or 1 gram per dose in a vaginal product;(16.83) Norgestrel - 0.075 mg. tablet when used for the prevention of pregnancy;(16.85) Olopatadine hydrochloride - When used with a strength of 0.7 percent or less in an ophthalmic solution;(16.9) Omeprazole - when a single dosage unit is 20.6 mg. or less;(16.92) Any opioid antagonist, as defined in Code Section 26-4-116.2, shall also be exempt from subsections (a) and (b) of this Code section when used for drug overdose prevention and when supplied by a dispenser or an authorized wholesale distributor.(16.95) Orlistat - when a single dosage unit is 60 mg. or less;(16.97) Oxybutynin - when a single dose is delivered as 3.9 mg. per day using a transdermal system patch;(17) Oxygen - compressed oxygen which is not labeled "CAUTION: Federal law prohibits dispensing without prescription" or similar wording;(17.3) Permethrin - when used as a topical preparation in a strength of 1 percent or less;(17.5) Phenazopyridine - where a single dose is 100 mg. or less, as approved by the federal Food and Drug Administration;(18) Pheniramine - when the oral dose is 25 mg. or less, or when used in an ophthalmic solution in a concentration of 0.315 percent or less in combination with a naphazoline concentration of 0.027 percent or less;(19) Polymyxin B when in combination with other drugs in an ointment or cream for topical use;(20) Any potassium electrolyte when manufactured for use as a dietary supplement, food additive for industrial, scientific, or commercial use, or when added to other drug products when the product is not intended as a potassium supplement but must bear such labels and adhere to such restrictions of FDA regulations;(21) Povidone - Iodine solutions and suspensions;(23.5) Ranitidine - when a single dosage unit is 150 mg. or less;(24) Rutin - where the dosage unit is less than 60 mg.;(25) Selenium sulfide suspension 1 percent or less in strength;(25.05) Sodium chloride injection - when in quantities of 10 cc or less and used as a catheter flush solution to act by physically occupying space within a catheter and exerting pressure on the patient's circulating blood;(25.1) Strychnine - when used in combination with other active ingredients in a rodent killer, and when not bearing a label containing the words "CAUTION: Federal law prohibits dispensing without prescription" or other similar wording;(25.5) Terbinafine - when used with a strength of 1 percent or less in a topical antifungal cream;(26) Tetrahydrozoline for ophthalmic or topical use;(27) Theophylline preparations alone or in combination with other drugs prepared for and approved for OTC (over the counter) sale by FDA; example - tedral tablets (plain) or oral suspension;(27.5) Tioconazole - when used with a strength of 1 percent or less in topical preparations or when used with a strength of 6.5 percent or less in vaginal preparations;(27.7) Triamcinolone acetonide - when used in a nasal spray that delivers 55 mcg. per spray or less;(28) Tripelennamine cream or ointment for topical use;(28.5) Triprolidine - when a single dose is 5 mg. or less when combined in the same preparation as one or more other drug products for use as an antihistamine or decongestant or an antihistamine and decongestant;(29) Urea - except when the manufacturer's label contains the wording "CAUTION: Federal law prohibits dispensing without prescription" or similar wording;(29.5) Zinc acetate - when used in topical preparations;(30) Any drug approved by FDA for animal use and the package does not bear the statement "CAUTION: Federal law prohibits dispensing without prescription" or similar wording; or(31) Loperamide Oral Liquid (1.00 mg./5.00 ml.).(d) The following list of compounds or preparations may be purchased without a prescription, provided the products are manufactured for industrial, scientific, or commercial sale or use, unless they are intended for human use or contain on the label "CAUTION: Federal law prohibits dispensing without prescription" or similar wording: (2) Aminosalicylate calcium;(3) Aminosalicylate potassium;(4) Aminosalicylate sodium;(8) Bismuth sodium tartrate;(10) Calcium disodium edetate;(11) Cellulose, Oxadized, Regenerated;(36) Potassium aminosalicylate;(37) Potassium p-aminobenzoate;(37.5) Potassium perchlorate;(38) Potassium permanganate;(39) Resorcinol monoacetate;(45) Trichloroacetic acid;(49) 4-chloro-3, 5-xylenol.(e) The State Board of Pharmacy may delete drugs from the dangerous drug list set forth in this Code section. In making such deletions the board shall consider, with respect to each drug, the following factors:(1) The actual or relative potential for abuse;(2) The scientific evidence of its pharmacological effect, if known;(3) The state of current scientific knowledge regarding the drug;(4) The history and current pattern of abuse, if any;(5) The scope, duration, and significance of abuse;(7) The potential of the drug to produce psychic or physiological dependence liability; and(8) Whether such drug is included under the federal Food, Drug, and Cosmetic Act, 52 Stat. 1040 (1938), 21 U.S.C. Section 301, et seq., as amended.Amended by 2024 Ga. Laws 462,§ 1, eff. 7/1/2024.Amended by 2024 Ga. Laws 411,§ 11, eff. 4/22/2024.Amended by 2024 Ga. Laws 411,§ 10, eff. 4/22/2024.Amended by 2024 Ga. Laws 411,§ 9, eff. 4/22/2024.Amended by 2024 Ga. Laws 411,§ 8, eff. 4/22/2024.Amended by 2024 Ga. Laws 411,§ 7, eff. 4/22/2024.Amended by 2023 Ga. Laws 66,§ 7, eff. 5/1/2023.Amended by 2023 Ga. Laws 66,§ 6, eff. 5/1/2023.Amended by 2023 Ga. Laws 66,§ 5, eff. 5/1/2023.Amended by 2022 Ga. Laws 877,§ 9, eff. 5/13/2022.Amended by 2022 Ga. Laws 877,§ 8, eff. 5/13/2022.Amended by 2022 Ga. Laws 877,§ 7, eff. 5/13/2022.Amended by 2021 Ga. Laws 307,§ 16, eff. 5/10/2021.Amended by 2021 Ga. Laws 191,§ 10, eff. 5/4/2021.Amended by 2021 Ga. Laws 191,§ 9, eff. 5/4/2021.Amended by 2021 Ga. Laws 191,§ 8, eff. 5/4/2021.Amended by 2020 Ga. Laws 521,§ 16, eff. 7/29/2020.Amended by 2020 Ga. Laws 388,§ 1, eff. 7/1/2020.Amended by 2020 Ga. Laws 372,§ 4, eff. 6/29/2020.Amended by 2020 Ga. Laws 372,§ 3, eff. 6/29/2020.Amended by 2020 Ga. Laws 372,§ 2, eff. 6/29/2020.Amended by 2019 Ga. Laws 267,§ 12, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 11, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 10, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 9, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 8, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 7, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 6, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 5, eff. 5/7/2019.Amended by 2019 Ga. Laws 267,§ 4, eff. 5/7/2019.Amended by 2018 Ga. Laws 373,§ 9, eff. 5/3/2018.Amended by 2018 Ga. Laws 373,§ 8, eff. 5/3/2018.Amended by 2018 Ga. Laws 373,§ 7, eff. 5/3/2018.Amended by 2018 Ga. Laws 373,§ 6, eff. 5/3/2018.Amended by 2017 Ga. Laws 275,§ 16, eff. 5/9/2017.Amended by 2017 Ga. Laws 141,§ 1-3 and § 1-4, eff. 7/1/2017.Amended by 2017 Ga. Laws 19,§ 2 and § 3, eff. 4/18/2017.Amended by 2017 Ga. Laws 17,§ 9 to § 11, eff. 4/17/2017.Amended by 2016 Ga. Laws 625,§ 16, eff. 5/3/2016.Amended by 2016 Ga. Laws 603,§ 5 to § 8, eff. 5/3/2016.Amended by 2015 Ga. Laws 125,§ 5 and § 6, eff. 5/6/2015.Amended by 2015 Ga. Laws 9,§ 16, eff. 3/13/2015.Amended by 2014 Ga. Laws 669,§ 16, eff. 4/29/2014.Amended by 2014 Ga. Laws 518,§ 6 and § 7, eff. 4/15/2014.Amended by 2013 Ga. Laws 20,§ 3 to § 5, eff. 4/18/2013.Amended by 2012 Ga. Laws 434,§ 5, eff. 3/27/2012.Amended by 2011 Ga. Laws 228,§ 8 to § 10, eff. 5/13/2011.Amended by 2011 Ga. Laws 228,§ 7, eff. 5/13/2011.Amended by 2010 Ga. Laws 629,§ 1, eff. 7/1/2010.Amended by 2010 Ga. Laws 619,§ 5 to § 7, eff. 6/4/2010.Amended by 2009 Ga. Laws 43,§ 5, eff. 4/21/2009.Amended by 2008 Ga. Laws 433,§ 6 to § 8, eff. 5/6/2008.Amended by 2007 Ga. Laws 331,§ 3 to § 5, eff. 5/29/2007.Amended by 2007 Ga. Laws 18,§ 16, eff. 5/11/2007.Amended by 2006 Ga. Laws 516,§ 3 to § 5, eff. 4/19/2006.Amended by 2005 Ga. Laws 330,§ 2 and § 3, eff. 5/9/2005.Amended by 2004 Ga. Laws 526, §§ 4 to 7, eff. 5/13/2004.Amended by 2003 Ga. Laws 80, § 11, eff. 5/29/2003.Amended by 2003 Ga. Laws 80, § 10, eff. 5/29/2003.Amended by 2003 Ga. Laws 80, § 9, eff. 5/29/2003.Amended by 2003 Ga. Laws 80, § 8, eff. 5/29/2003.Amended by 2001 Ga. Laws 260§ 6, eff. 4/27/2001.Amended by 2001 Ga. Laws 260§ 5, eff. 4/27/2001.Amended by 2001 Ga. Laws 260§ 4, eff. 4/27/2001.